This systematic review highlights elevated cutaneous malignancy risks in pediatric patients after allogeneic HSCT, emphasizing the need for long-term monitoring. The findings underscore the significance of enhanced surveillance and preventive measures to mitigate these risks.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username